ALLE vs CSL

ALLE's Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive distress risk assessment. The company trades above its Graham Number of $61.34 at a current price of $166.80, reflecting a significant premium, though justified in part by solid profitability metrics including a 36.41% ROE and consistent earnings growth. Despite strong historical earnings surprises and solid margins, elevated valuation multiples and bearish insider activity temper upside potential. Analysts concur with a 'hold' recommendation, aligning with the neutral stance.

CSL exhibits a stable but mediocre Piotroski F-Score of 4/9, indicating a lack of strong financial momentum. The stock is trading at a massive premium, with a current price of $360.07 far exceeding both the Graham Number ($130.25) and the Intrinsic Value ($120.26). This valuation gap is exacerbated by stagnant revenue growth (0.40%) and sharply declining earnings growth (-14.60% YoY). Despite strong ROE and liquidity, the combination of bearish insider selling by the CEO and CFO and a technical trend of 0/100 suggests significant downside risk.